Discover more insights into Toxicity Outcomes 독성 결과

Keywords frequently search together with Toxicity Outcomes 독성 결과

Narrow sentence examples with built-in keyword filters

Toxicity Outcomes sentence examples within intermediate risk prostate



Impact of a dominant intraprostatic lesion (DIL) boost defined by sextant biopsy in permanent I-125 prostate implants on biochemical disease free survival (bDFS) and toxicity outcomes.


Five-Year Outcomes of a Phase 1 Dose-Escalation Study Using Stereotactic Body Radiosurgery for Patients With Low-Risk and Intermediate-Risk Prostate Cancer.

Toxicity Outcomes sentence examples within risk prostate cancer



Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space

Toxicity Outcomes sentence examples within low dose rate



Impact of Hydrogel and Hyaluronic Acid Rectal Spacer on Rectal Dosimetry and Toxicity in Low-Dose-Rate Prostate Brachytherapy: A Multi-Institutional Analysis of Patient Outcomes.



Toxicity Outcomes sentence examples within cancer patients treated



Influence of Hydrogel Spacer Placement with Prostate Brachytherapy on Rectal and Urinary Toxicity.

Toxicity Outcomes sentence examples within Late Toxicity Outcomes



Five-Fraction Prone Accelerated Partial Breast Irradiation: Long-Term Oncologic, Dosimetric, and Cosmetic Outcome.


A Comparison of Radiation Toxicity Outcomes in Patients With and Without Autoimmune Diagnoses on the REQUITE Study.

Toxicity Outcomes sentence examples within Improved Toxicity Outcomes



Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma


Gene Alterations as Predictors of Radiation-Induced Toxicity in Head and Neck Squamous Cell Carcinoma

Toxicity Outcomes sentence examples within Reported Toxicity Outcomes



Pulmonary Toxicity After Total Body Irradiation – Critical Review of the Literature and Recommendations for Toxicity Reporting


Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer

Toxicity Outcomes sentence examples within Acute Toxicity Outcomes



Arsenic exposure from groundwater: environmental contamination, human health effects, and sustainable solutions


Minimal acute toxicity from proton beam therapy for major salivary gland cancer

Toxicity Outcomes sentence examples within Limiting Toxicity Outcomes



A Bayesian dose-finding design for outcomes evaluated with uncertainty


Coherence principles in interval-based dose finding.

Toxicity Outcomes sentence examples within Compared Toxicity Outcomes



The Acute and Late Toxicities of MRI-Guided External Beam Partial Breast Irradiation Delivered Using a Once-Per-Day Regimen


The Acute and Late Toxicities of MRI-Guided External Beam Partial Breast Irradiation Delivered Using a Once-per-Day Regimen.

Toxicity Outcomes sentence examples within toxicity outcomes compared



Microplastic fibers influence Ag toxicity and bioaccumulation in Eisenia andrei but not in Enchytraeus crypticus


Microplastic fibers influence Ag toxicity and bioaccumulation in Eisenia andrei but not in Enchytraeus crypticus

Toxicity Outcomes sentence examples within toxicity outcomes according



Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity Following Prostate SBRT: A Combined Analysis of 23 Prospective Clinical Trials.


Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel-A pooled analysis of 3 randomized studies.


Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience



Comparative study on hemato- and nephrotoxicity profile of weekly versus every 3-weekly cisplatin dosage during induction chemotherapy in locally advanced head neck squamous cell carcinoma



Carbon Ion Radiotherapy for Treatment of Sacral Chordomas: An Institutional and International Comparison of Surgical and Conventional Radiotherapy Outcomes



Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review



Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †



Stereotactic Radiotherapy for Recurrent Post-Transplant Primary Central Nervous System Lymphoma



Validation of the 3D reconstructed human skin micronucleus (RSMN) assay: an animal-free alternative for following-up positive results from standard in vitro genotoxicity assays



Long-term outcomes of spinal SBRT. Is it important to select the treatment time?



Breast radiotherapy-related treatment outcomes in patients with or without germline mutations on multigene panel testing.



Proton Therapy and Gliomas: A Systematic Review



Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer



Multilayered Cell Sheets of Cardiac Reprogrammed Cells for the Evaluation of Drug Cytotoxicity.



Hypofractionated vs. Twice Daily Radiotherapy for Limited Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.



Optimal policy determination in sequential systemic and locoregional therapy of oropharyngeal squamous carcinomas: A patient-physician digital twin dyad with deep Q-learning for treatment selection.



Effect of concomitant use of antihypertensives and immune check point inhibitors on cancer outcomes



Physiological Effects of Neonicotinoid Insecticides on Non-Target Aquatic Animals—An Updated Review



Prevalence of Palliative Radiotherapy Abstracts Presented at Annual Scientific Meetings of the Canadian Association of Radiation Oncology: 2009-2020.



Testing for similarity of binary efficacy-toxicity responses.



In vitro antifungal activity of Thymus vulgaris essential oil nanoemulsion



Repeat-dose toxicity prediction with Generalized Read-Across (GenRA) using targeted transcriptomic data: A proof-of-concept case study



A pragmatic approach to Adverse Outcome Pathway (AOP) development and evaluation.



Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy



Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Cervical Cancer Not Amenable to Brachytherapy.



Genetic Alterations as Predictors of Radiation-Induced Toxicity in Head and Neck Squamous Cell Carcinoma.



Comparison of clinical outcomes achieved with image-guided adaptive brachytherapy for cervix cancer using CT or transabdominal ultrasound.



Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.



Bayesian phase II clinical trial design with noncompliance.



Comparison of Clinical and Toxicity Outcomes of Adenoid Cystic Carcinomas Treated With Intensity Modulated Radiation Therapy vs. Proton Radiotherapy.



A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis



Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and Toxicity.



Clinical Outcomes of Patients Treated With Intensity Modulated Proton Therapy (IMPT) Re-Irradiation for Gynecologic Malignancies.



A Comparison of Hypofractionated and Twice Daily Thoracic Irradiation in Limited-Stage Small Cell Lung Cancer: An Overlap Weighted Analysis.



Acute and late side-effects after low dose-rate brachytherapy for prostate cancer; incidence, management and technical considerations.



The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy



Impact of travel distance on outcomes for clinical trial patients - The Kinghorn Cancer Centre (TKCC) Experience.



The Promise of Proton Beam Therapy for Oesophageal Cancer: A Systematic Review of Dosimetric and Clinical Outcomes.



Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review



Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment



Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice



An Integrative Workflow to Prioritize Toxicity Initiation Events From Air-liquid-interface Exposure of Human Lung Cells to Combustion Aerosols: First Application to Emissions From a Heavy Fuel Oil or Diesel Fuel Operated Ship Engine



A utility approach to individualized optimal dose selection using biomarkers.



Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?



Long-term outcomes of bladder preservation in muscle-invasive bladder cancer patients



A Retrospective Study of Blinatumomab Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed and Refractory ALL



Adjuvant Management of Advanced High-Risk Salivary Gland Malignancy



Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.



Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis



Optimal design to discriminate between rival copula models for a bivariate binary response



Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes



A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity data.



Survival and toxicity outcomes in patients age 40 or older with relapsed metastatic germ cell tumors (mGCT) treated with high-dose chemotherapy (HDCT) and autologous peripheral-blood stem cell transplant (PBSCT).



Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature.



Safety of Prostate Stereotactic Body Radiation Therapy after Transurethral Resection of Prostate (TURP): A Propensity Score Matched Pair Analysis.



PoD-TPI: Probability-of-Decision Toxicity Probability Interval Design to Accelerate Phase I Trials



Spine radiosurgery in adolescents and young adults: early outcomes and toxicity in patients with metastatic Ewing sarcoma and osteosarcoma.



The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma



Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)



Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Clinical Trial



Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy



A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis



Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials



PSMA-PET Guided Dose-Escalated Volumetric Arc Therapy (VMAT) for newly Diagnosed Node Positive Prostate Cancer: Efficacy and Toxicity Outcomes at Two Years



Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas


More Toxicity Outcomes 독성 결과 sentence examples
10.1136/archdischild-2019-rcpch.519

G536 Effectiveness of hydroxycarbamide in children with sickle cell disease – analysis of dose-response metrics in a large birth cohort in a tertiary sickle cell centre



Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis.



Gefitinib with or without Transarterial Infusion Chemotherapy (Cisplatin) for Large Nonsmall Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations.



Trifluridine/tipiracil in metastatic colorectal cancer: An updated multicentre real-world analysis on efficacy, safety and predictive factors


Learn more from Toxicity Outcomes 독성 결과

Toxicity Outcomes 독성 결과


Toxicity Outcomes 독성 결과
Encyclopedia 백과사전